Evaluación y manejo del riesgo cardiovascular en infección por VIH. Consenso de expertos ACIN

Valderrama Beltrán, Sandra Liliana; Gualtero, Sandra Milena; Quiroga, Camilo; Garzón, Javier Ricardo; Lowenstein de Mendivelson, Ellen; Tamara, Jose Roberto; Garcia, Angel; Álvarez, Carlos; Castañeda, Carlos; Cataño, Juan Carlos; Botero, Claudia Pilar; Guevara, Freddy; García, José Fernando; Oñate, José; Posada, María Paulina; Sussmann, Otto; Zuluaga De León, Iván J; Arévalo-Mora, Leonardo; Martínez Buitrago, Ernesto.
Infectio ; 23(supl.1): 73-91, dic. 2019. tab, graf
Artigo em Espanhol | LILACS, COLNAL | ID: biblio-984511

Documentos relacionados

  1. MAFLD is associated with increased all-cause mortality in low cardiovascular-risk individuals but not in intermediate to high-risk individuals.
  2. Asking informed consent may lead to significant participation bias and suboptimal cardiovascular risk management in learning healthcare systems.
  3. Identification of the specific molecular and functional signatures of pre-beta-HDL: relevance to cardiovascular disease.
  4. Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial.
  5. Escala predictiva de mortalidad por afección cardiovascular en adultos mayores del municipio de Santiago de Cuba
  6. VIH, dislipidemias y perspectivas de su evolución
  7. Clarifying the Link Between the Blood Lactate Concentration and Cardiovascular Risk.
  8. Childhood Risk Factors and Adulthood Cardiovascular Disease: A Systematic Review.
  9. Joint replacement and cardiovascular health.
  10. Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease.